Sense and antisense peptides to treat multiple sclerosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/08 (2006.01) A61K 35/76 (2006.01) A61K 38/03 (2006.01) A61K 38/19 (2006.01) C07K 14/47 (2006.01) G01N 33/564 (2006.01)

Patent

CA 2201274

This invention pertains to the novel use of sense and antisense peptides for the treatment of demyelinating disease. A method for identifying epitopes which become exposed in degenerating myelin is described, as well as methods for designing stable peptides to neutralize the immunogenic effect of the epitopes.

L'invention concerne l'utilisation nouvelle de peptides sens et antisens pour traiter une maladie démyélinisante. On décrit également une méthode d'identification des épitopes qui deviennent exposés dans la myéline en dégénératio, ainsi que des méthodes pour concevoir des peptides stables qui neutraliseront l'effet immunogène des épitopes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sense and antisense peptides to treat multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sense and antisense peptides to treat multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sense and antisense peptides to treat multiple sclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1444072

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.